Report Detail
Global Choroidal Neovascularization Market Professional Survey Report 2019
- RnM3776141 |
- 24 September, 2019 |
- Global |
- 108 Pages |
- QYResearch |
- Other
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Choroidal Neovascularization volume and value at global level, regional level and company level. From a global perspective, this report represents overall Choroidal Neovascularization market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Choroidal Neovascularization in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Choroidal Neovascularization manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Valeant Pharmaceuticals International Inc.
Gilead Sciences Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Intravenous
Intravitreal
Segment by Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Table of Contents
Executive Summary
1 Industry Overview of Choroidal Neovascularization
- 1.1 Definition of Choroidal Neovascularization
- 1.2 Choroidal Neovascularization Segment by Type
- 1.2.1 Global Choroidal Neovascularization Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Intravenous
- 1.2.3 Intravitreal
- 1.3 Choroidal Neovascularization Segment by Applications
- 1.3.1 Global Choroidal Neovascularization Consumption Comparison by Applications (2014-2025)
- 1.3.2 Extreme Myopia
- 1.3.3 Malignant Myopic Degeneration
- 1.3.4 Age-Related Developments
- 1.4 Global Choroidal Neovascularization Overall Market
- 1.4.1 Global Choroidal Neovascularization Revenue (2014-2025)
- 1.4.2 Global Choroidal Neovascularization Production (2014-2025)
- 1.4.3 North America Choroidal Neovascularization Status and Prospect (2014-2025)
- 1.4.4 Europe Choroidal Neovascularization Status and Prospect (2014-2025)
- 1.4.5 China Choroidal Neovascularization Status and Prospect (2014-2025)
- 1.4.6 Japan Choroidal Neovascularization Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Choroidal Neovascularization Status and Prospect (2014-2025)
- 1.4.8 India Choroidal Neovascularization Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization
- 2.3 Manufacturing Process Analysis of Choroidal Neovascularization
- 2.4 Industry Chain Structure of Choroidal Neovascularization
3 Development and Manufacturing Plants Analysis of Choroidal Neovascularization
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Choroidal Neovascularization Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Choroidal Neovascularization
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Choroidal Neovascularization Production and Capacity Analysis
- 4.2 Choroidal Neovascularization Revenue Analysis
- 4.3 Choroidal Neovascularization Price Analysis
- 4.4 Market Concentration Degree
5 Choroidal Neovascularization Regional Market Analysis
- 5.1 Choroidal Neovascularization Production by Regions
- 5.1.1 Global Choroidal Neovascularization Production by Regions
- 5.1.2 Global Choroidal Neovascularization Revenue by Regions
- 5.2 Choroidal Neovascularization Consumption by Regions
- 5.3 North America Choroidal Neovascularization Market Analysis
- 5.3.1 North America Choroidal Neovascularization Production
- 5.3.2 North America Choroidal Neovascularization Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Choroidal Neovascularization Import and Export
- 5.4 Europe Choroidal Neovascularization Market Analysis
- 5.4.1 Europe Choroidal Neovascularization Production
- 5.4.2 Europe Choroidal Neovascularization Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Choroidal Neovascularization Import and Export
- 5.5 China Choroidal Neovascularization Market Analysis
- 5.5.1 China Choroidal Neovascularization Production
- 5.5.2 China Choroidal Neovascularization Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Choroidal Neovascularization Import and Export
- 5.6 Japan Choroidal Neovascularization Market Analysis
- 5.6.1 Japan Choroidal Neovascularization Production
- 5.6.2 Japan Choroidal Neovascularization Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Choroidal Neovascularization Import and Export
- 5.7 Southeast Asia Choroidal Neovascularization Market Analysis
- 5.7.1 Southeast Asia Choroidal Neovascularization Production
- 5.7.2 Southeast Asia Choroidal Neovascularization Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Choroidal Neovascularization Import and Export
- 5.8 India Choroidal Neovascularization Market Analysis
- 5.8.1 India Choroidal Neovascularization Production
- 5.8.2 India Choroidal Neovascularization Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Choroidal Neovascularization Import and Export
6 Choroidal Neovascularization Segment Market Analysis (by Type)
- 6.1 Global Choroidal Neovascularization Production by Type
- 6.2 Global Choroidal Neovascularization Revenue by Type
- 6.3 Choroidal Neovascularization Price by Type
7 Choroidal Neovascularization Segment Market Analysis (by Application)
- 7.1 Global Choroidal Neovascularization Consumption by Application
- 7.2 Global Choroidal Neovascularization Consumption Market Share by Application (2014-2019)
8 Choroidal Neovascularization Major Manufacturers Analysis
- 8.1 Pfizer Inc.
- 8.1.1 Pfizer Inc. Choroidal Neovascularization Production Sites and Area Served
- 8.1.2 Pfizer Inc. Product Introduction, Application and Specification
- 8.1.3 Pfizer Inc. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 F. Hoffmann-La Roche Ltd.
- 8.2.1 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Production Sites and Area Served
- 8.2.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
- 8.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Novartis AG
- 8.3.1 Novartis AG Choroidal Neovascularization Production Sites and Area Served
- 8.3.2 Novartis AG Product Introduction, Application and Specification
- 8.3.3 Novartis AG Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Regeneron Pharmaceuticals Inc.
- 8.4.1 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Production Sites and Area Served
- 8.4.2 Regeneron Pharmaceuticals Inc. Product Introduction, Application and Specification
- 8.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Bayer AG
- 8.5.1 Bayer AG Choroidal Neovascularization Production Sites and Area Served
- 8.5.2 Bayer AG Product Introduction, Application and Specification
- 8.5.3 Bayer AG Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 QLT Inc.
- 8.6.1 QLT Inc. Choroidal Neovascularization Production Sites and Area Served
- 8.6.2 QLT Inc. Product Introduction, Application and Specification
- 8.6.3 QLT Inc. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Sanwa Kagaku Kenkyusho Co. Ltd.
- 8.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Production Sites and Area Served
- 8.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Product Introduction, Application and Specification
- 8.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Promedior Inc.
- 8.8.1 Promedior Inc. Choroidal Neovascularization Production Sites and Area Served
- 8.8.2 Promedior Inc. Product Introduction, Application and Specification
- 8.8.3 Promedior Inc. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Valeant Pharmaceuticals International Inc.
- 8.9.1 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Production Sites and Area Served
- 8.9.2 Valeant Pharmaceuticals International Inc. Product Introduction, Application and Specification
- 8.9.3 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Gilead Sciences Inc
- 8.10.1 Gilead Sciences Inc Choroidal Neovascularization Production Sites and Area Served
- 8.10.2 Gilead Sciences Inc Product Introduction, Application and Specification
- 8.10.3 Gilead Sciences Inc Choroidal Neovascularization Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Choroidal Neovascularization Market
- 9.1 Global Choroidal Neovascularization Market Trend Analysis
- 9.1.1 Global Choroidal Neovascularization Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Choroidal Neovascularization Regional Market Trend
- 9.2.1 North America Choroidal Neovascularization Forecast 2019-2025
- 9.2.2 Europe Choroidal Neovascularization Forecast 2019-2025
- 9.2.3 China Choroidal Neovascularization Forecast 2019-2025
- 9.2.4 Japan Choroidal Neovascularization Forecast 2019-2025
- 9.2.5 Southeast Asia Choroidal Neovascularization Forecast 2019-2025
- 9.2.6 India Choroidal Neovascularization Forecast 2019-2025
- 9.3 Choroidal Neovascularization Market Trend (Product Type)
- 9.4 Choroidal Neovascularization Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Choroidal Neovascularization Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Choroidal Neovascularization. Industry analysis & Market Report on Choroidal Neovascularization is a syndicated market report, published as Global Choroidal Neovascularization Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Choroidal Neovascularization market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
